BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody

  November 4, 2025

   · 

  9 min read
• Press Releases

  Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2025

  November 4, 2025

   · 

  2 min read
• Press Releases

  Cardiff Oncology to Participate in Two Upcoming Investor Conferences - November 4, 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

  November 4, 2025

   · 

  19 min read
• Press Releases

  Supernus Announces Third Quarter 2025 Financial Results

  November 4, 2025

   · 

  19 min read
• Press Releases

  Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences

  November 4, 2025

   · 

  7 min read
• Press Releases

  Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update

  November 4, 2025

   · 

  2 min read
• Press Releases

  Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

  November 4, 2025

   · 

  10 min read
• Press Releases

  Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

  November 4, 2025

   · 

  7 min read